Á lódáil...
MEK inhibitors against MET-amplified non-small cell lung cancer
Several receptor tyrosine kinases (RTKs) including EGFR, ALK, and MET have been identified as therapeutic targets in non-small cell lung cancer (NSCLC). Among the downstream pathways of RTKs, the MAPK pathway is particularly important for cancer cell proliferation, differentiation, and survival. In...
Na minha lista:
| Foilsithe in: | Int J Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
D.A. Spandidos
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118002/ https://ncbi.nlm.nih.gov/pubmed/27748834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3736 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|